387 related articles for article (PubMed ID: 26135958)
1. Roles of A20 in autoimmune diseases.
Zhang M; Peng LL; Wang Y; Wang JS; Liu J; Liu MM; Hu J; Song B; Yang HB
Immunol Res; 2016 Apr; 64(2):337-44. PubMed ID: 26135958
[TBL] [Abstract][Full Text] [Related]
2. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
[TBL] [Abstract][Full Text] [Related]
3. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
4. Dissection and function of autoimmunity-associated TNFAIP3 (A20) gene enhancers in humanized mouse models.
Sokhi UK; Liber MP; Frye L; Park S; Kang K; Pannellini T; Zhao B; Norinsky R; Ivashkiv LB; Gong S
Nat Commun; 2018 Feb; 9(1):658. PubMed ID: 29440643
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
6. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
7. Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.
He T; Huang Y; Luo Y; Xia Y; Wang L; Zhang H; Ling J; Yang J
J Clin Immunol; 2020 Jul; 40(5):741-751. PubMed ID: 32514655
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
He Y; Xu LL; Feng FE; Wang QM; Zhu XL; Wang CC; Zhang JM; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
Br J Haematol; 2018 Feb; 180(3):395-411. PubMed ID: 29327472
[TBL] [Abstract][Full Text] [Related]
9. A20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity.
Martens A; van Loo G
Cold Spring Harb Perspect Biol; 2020 Jan; 12(1):. PubMed ID: 31427375
[TBL] [Abstract][Full Text] [Related]
10. Recent advances of exosomes in immune modulation and autoimmune diseases.
Tan L; Wu H; Liu Y; Zhao M; Li D; Lu Q
Autoimmunity; 2016 Sep; 49(6):357-365. PubMed ID: 27259064
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
[TBL] [Abstract][Full Text] [Related]
12. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.
Vereecke L; Beyaert R; van Loo G
Biochem Soc Trans; 2011 Aug; 39(4):1086-91. PubMed ID: 21787353
[TBL] [Abstract][Full Text] [Related]
13. Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in
Duncan CJA; Dinnigan E; Theobald R; Grainger A; Skelton AJ; Hussain R; Willet JDP; Swan DJ; Coxhead J; Thomas MF; Thomas J; Zamvar V; Slatter MA; Cant AJ; Engelhardt KR; Hambleton S
Ann Rheum Dis; 2018 May; 77(5):783-786. PubMed ID: 28659290
[No Abstract] [Full Text] [Related]
14. Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.
Van Damme KFA; Hertens P; Martens A; Gilis E; Priem D; Bruggeman I; Fossoul A; Declercq J; Aegerter H; Wullaert A; Hochepied T; Hoste E; Vande Walle L; Lamkanfi M; Savvides SN; Elewaut D; Lambrecht BN; van Loo G
Sci Rep; 2023 Oct; 13(1):17992. PubMed ID: 37865713
[TBL] [Abstract][Full Text] [Related]
15. A20 Inhibits Intraocular Inflammation in Mice by Regulating the Function of CD4+T Cells and RPE Cells.
Hu J; Yi S; Wang C; Zhang Y; Tang J; Huang X; Yang L; Yang J; Li H
Front Immunol; 2020; 11():603939. PubMed ID: 33613524
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.
Hamerman JA; Pottle J; Ni M; He Y; Zhang ZY; Buckner JH
Immunol Rev; 2016 Jan; 269(1):212-27. PubMed ID: 26683155
[TBL] [Abstract][Full Text] [Related]
17. TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus.
Wang S; Wen F; Tessneer KL; Gaffney PM
Genes Immun; 2016 Apr; 17(3):165-70. PubMed ID: 26821284
[TBL] [Abstract][Full Text] [Related]
18. A20: a master regulator of arthritis.
Wu Y; He X; Huang N; Yu J; Shao B
Arthritis Res Ther; 2020 Sep; 22(1):220. PubMed ID: 32958016
[TBL] [Abstract][Full Text] [Related]
19. An Autoimmune Disease-Associated Risk Variant in the
Lou L; Bao W; Liu X; Song H; Wang Y; Zhang K; Gao W; Li H; Tu Z; Wang S
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343543
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic changes in inflammatory and autoimmune diseases.
Nielsen HM; Tost J
Subcell Biochem; 2013; 61():455-78. PubMed ID: 23150263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
